Outside of corporate building with blue windows

Media

Our latest news, announcements and multimedia resources

Latest news

February 12, 2026

Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium

February 11, 2026

KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment

February 3, 2026

Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline

January 27, 2026

Merck Announces Second-Quarter 2026 Dividend

January 20, 2026

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

January 7, 2026

Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC

February 3, 2026

Merck remembers Dr. William Foege, Architect of Early Mectizan® Delivery Efforts

January 8, 2026

Merck Statement on the U.S. Child and Adolescent Immunization Schedule

Merck Expands Innovative Internal Generative AI Solutions Helping to Deliver Medicines to Patients Faster

Merck Statement on a Potential Reduced Dosing Recommendation for GARDASIL®9

January 2, 2025

Merck honors the life and legacy of President Jimmy Carter

November 20, 2024

Merck Foundation Heightens Focus on Advancing Equity in Cardiac Care Across the U.S.

Media resources

Bright light tubes against a silver wall

News releases

Read our latest news releases.

Underside of a staircase

Company statements

Read our latest company statements.

Man reviewing post-it-notes on glass wall

Media library

Access videos, logos, photos and infographics.

Media contacts

Global media relations

+1 908-740-5633

mediarelations@merck.com

Get to know us through our stories

Everything we do, in and out of the laboratory, is based on our deep appreciation for life. Get a glimpse of what it’s like on the inside through our stories.

Scientist reviewing test tubes

We are driven by a single purpose

We use the power of leading-edge science to save and improve lives around the world.

Learn more about our company

Person reviewing product pipeline on their smartphone

Investor relations

Find our latest financials, events & presentations, news, stock information and investor contacts.

Visit investor relations

Two employees in the lobby on their laptops

Company fact sheet

Access company information including stock ticker, official company names, description, and more.

See company fact sheet

Unsubscribe from email alerts